Daunorubicin Congeners with DNA DNA Topoisomerase II-mediated Interaction of Doxorubicin and Updated Version
暂无分享,去创建一个
[1] M. Israel,et al. Comparative effects of adriamycin and DNA-non-binding analogues on DNA, RNA, and protein synthesis in vitro , 2004, Cancer Chemotherapy and Pharmacology.
[2] F. Traganos,et al. Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II. , 1988, Cancer research.
[3] S. Penco,et al. Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicin. , 1987, Cancer research.
[4] R. Seshadri,et al. Adriamycin analogues. Preparation and biological evaluation of some thio ester analogues of adriamycin and N-(trifluoroacetyl)adriamycin 14-valerate. , 1986, Journal of medicinal chemistry.
[5] C. Geroni,et al. In vitro studies on anthracycline haloderivatives. , 1986, Drugs under experimental and clinical research.
[6] M. Israel,et al. Interaction of three second-generation anthracyclines with polynucleotides, RNA, DNA, and nucleosomes. , 1986, Cancer research.
[7] W. Ross. DNA topoisomerases as targets for cancer therapy. , 1985, Biochemical pharmacology.
[8] L. Liu,et al. Purification and characterization of a type II DNA topoisomerase from bovine calf thymus. , 1985, The Journal of biological chemistry.
[9] H. Vosberg. DNA topoisomerases: enzymes that control DNA conformation. , 1985, Current topics in microbiology and immunology.
[10] L. Liu,et al. Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. , 1984, The Journal of biological chemistry.
[11] M. Israel,et al. Two mechanisms of adriamycin-DNA interaction in L1210 cells. , 1984, Biochemical pharmacology.
[12] M. Israel,et al. Relationship of adriamycin concentrations to the DNA lesions induced in hypoxic and euoxic L1210 cells. , 1983, Cancer research.
[13] Z. Darżynkiewicz,et al. In vivo effects of adriamycin or N-trifluoroacetyladriamycin-14-valerate on a mouse lymphoma. , 1983, European journal of cancer & clinical oncology.
[14] D. Patel,et al. Hydrogen bonding, overlap geometry, and sequence specificity in anthracycline antitumor antibiotic.DNA complexes in solution. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Israel,et al. Protein-associated DNA breaks and DNA-protein cross-links caused by DNA nonbinding derivatives of adriamycin in L1210 cells. , 1981, Cancer research.
[16] A. Rich,et al. Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG). , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[17] L. Chuang,et al. Inhibition of chicken myeloblastosis RNA polymerase II activity in vitro by N‐trifluoroacetyladriamycin‐14‐valerate , 1980, FEBS letters.
[18] G. L. Tong,et al. Adriamycin analogues. 3. Synthesis of N-alkylated anthracyclines with enhanced efficacy and reduced cardiotoxicity. , 1979, Journal of medicinal chemistry.
[19] H. S. Schwartz,et al. Effects of N-trifluoroacetyladriamycin-14-valerate and related agents on DNA strand damage and thymidine incorporation in CCRF-CEM cells. , 1979, Cancer research.
[20] A. Mantovani,et al. Intercalation with DNA is a prerequisite for daunomycin, adriamycin and its congeners in inhibiting DNAase I. , 1978, Chemico-biological interactions.
[21] S. Hanessian,et al. Synthesis and antitumor activity of 4'-deoxydaunorubicin and 4'-deoxyadriamycin. , 1976, Journal of medicinal chemistry.
[22] F. Formelli,et al. Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone. , 1975, Journal of medicinal chemistry.
[23] N. Bleehen,et al. Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line. , 1975, British Journal of Cancer.
[24] S. Barranco,et al. Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin. , 1974, Cancer research.
[25] R. Geran,et al. PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS , 1972 .
[26] H. Lazarus,et al. The response in vitro, of continuous cultures of human lymphoblasts (CCRF-CEM cells) to chemotherapeutic agents. , 1967, Biochemical pharmacology.